Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Gadoquatrane in Healthy Japanese Men
NCT06125366Phase 1Completed
- Sponsor
- Bayer
- Start
- Apr 2019
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial comparing Dose escalation of BAY1747846 with Matching Placebo (2 arms). Primary endpoints: Number of participants with treatment-emergent adverse events and Severity of treatment-emergent adverse events. Started Apr 2019; status: completed.
02
Drugs
gadoquatrane
Beyond the preview
Go deeper on NCT06125366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06125366.